Archived Activities

This CME-certified video brunch activity is designed to provide clinicians with expert guidance on healthcare maintenance guidelines and consensus statements for IBD patients and navigate how to implement these strategies for optimal clinical outcomes with particular focus on vulnerable populations.

This CME-certified Tweetorial is designed to provide clinicians with expert guidance on healthcare maintenance guidelines and consensus statements for IBD patients and navigate how to implement these strategies for optimal clinical outcomes with particular focus on vulnerable populations.

This CME-certified Tweetorial is designed to provide clinicians with expert guidance on healthcare maintenance guidelines and consensus statements for IBD patients and navigate how to implement these strategies for optimal clinical outcomes with particular focus on vulnerable populations.

This CME-certified Video Brunch is designed to provide clinicians with expert guidance on healthcare maintenance guidelines and consensus statements for IBD patients and navigate how to implement these strategies for optimal clinical outcomes with particular focus on vulnerable populations.

This CME-certified Tweetorial is designed to provide clinicians with expert guidance on healthcare maintenance guidelines and consensus statements for IBD patients and navigate how to implement these strategies for optimal clinical outcomes with particular focus on vulnerable populations.

This CME-certified Video Brunch is designed to provide clinicians with expert guidance on healthcare maintenance guidelines and consensus statements for IBD patients and navigate how to implement these strategies for optimal clinical outcomes with particular focus on vulnerable populations.

This CME-certified Tweetorial is designed to provide clinicians with expert guidance on healthcare maintenance guidelines and consensus statements for IBD patients and navigate how to implement these strategies for optimal clinical outcomes with particular focus on vulnerable populations.

This CME-certified Video Broadcast is designed to provide clinicians with expert guidance on health maintenance guidelines and consensus statements for IBD patients and navigate how to implement these strategies for optimal clinical outcomes with particular focus on vulnerable populations including adolescents, pregnant, postpartum, and elderly patients with IBD.

This CME-certified Tweetorial is designed to provide clinicians with expert guidance on healthcare maintenance guidelines and consensus statements for IBD patients and navigate how to implement these strategies for optimal clinical outcomes with particular focus on vulnerable populations.

This CME-certified Video Broadcast is designed to provide clinicians with expert guidance on healthcare maintenance guidelines and consensus statements for IBD patients and navigate how to implement these strategies for optimal clinical outcomes with particular focus on vulnerable populations.

In this CME-certified Tweetorial, we will explore outcomes for patients with RRMM, including health disparities that impact mortality, mortality trends and predictors of survival, and triple-class refractory disease.

In this CME-certified Tweetorial, we will explore the role of BCMA over-expression in Multiple Myeloma, mechanisms of action of bispecific antibodies, CAR-T, and ADC therapies, as well as mechanistic differences between these agents.

In this CME-certified, Twitter-based video activity, we will explore the efficacy of approved and emerging B cell maturation antigen (BCMA)-targeted agents including antibody-drug conjugates (ADC), chimeric antigen receptor (CAR)-T cells, and bispecific antibodies.

In this CME-certified, Twitter-based activity, we will explore outcomes for patients with RRMM, including health disparities that impact mortality, mortality trends and predictors of survival, and triple-class refractory disease.

In this CME-certified Tweetorial, we will explore diagnostic, prognostic, and potential predictive biomarkers in multiple myeloma, further delving into what we know about soluble BCMA.

This CME-certified Expert Roundtable explores COVID-19 Vaccines including efficacy and safety data of available vaccines, vaccine effectiveness and variants of concerns, boosters, and special populations.

In this CME-certified Newsroom session, Drs. Onyema Ogbuagu and Tara Smith will discuss data surrounding 3rd dose mRNA vaccination and impact on ED/UC visits and hospitalization as well as heterologous and homogenous vaccination strategies

In this CME-certified Newsroom session, Drs. Onyema Ogbuagu and Tara Smith will discuss data surrounding 3rd dose mRNA vaccination and impact on ED/UC visits and hospitalization as well as heterologous and homogenous vaccination strategies

In this CME-certified Newsroom session, Drs. Onyema Ogbuagu , Tara Smith, and Sten Vermund will discuss recent studies and publications about; hospitalizations outcomes of immunocompetent and immunocompromised vaccinated adults, effectiveness of the Pfizer-BioNtTech vaccine against hospitalization and MIS-C in teens, and results of vaccination studies on preterm and small for gestational age births of vaccinated mothers.

This CME-certified video Expert Roundtable will focus on recent clinical trials in ALL, highlight the importance of regimen adherence, navigate patient cases to determine treatment sequencing, and better understand treatment reactions and make appropriate clinical decisions based on reaction type.

With the recent approval of asparaginase erwinia chrysanthemi (recombinant)- rywn (ERW-rywn), health care professionals (HCPs) treating patients with ALL need to be informed of efficacy and safety data supporting ERW-rywn’s use. This CME-certified program will review the dosing, efficacy, and safety of ERW-rywn and compare this therapy to ERW.

This CME-certified, Twitter-based activity will review key posters presented at the ASH 2021 meeting. This session will focus on MRD considerations in the treatment of ALL, reviewing the results of the GMALL and UKALL 2003 trials.

During this Twitter-based CME activity, learners will have the opportunity to review results from the INITIAL 1 and the EWALL-INO studies, both assessing inotuzumab ozogamicin in the older patient with ALL. Additionally, the results of SWOG 1318, which studied blinatumomab followed by POMP maintenance in older patients with Ph-negative B-ALL will be discussed.

This CME-certified activity will focus on key studies presented at ASH 2021; including results from the Graaph-2014 (studied the omission of HD-AraC during consolidation of Ph-positive ALL patients treated with nilotinib and low-intensity chemotherapy) and the UKALL14 (assessment of addition of nelarabine to standard chemotherapy in T-cell ALL) trials.

This CME-certified, Twitter-based live virtual chat will allow participants and faculty to discuss the recent expansion of therapies and their practice-changing implications for how clinicians’ approach TNBC treatment, focusing on how to help close some of the practice barriers and deficits reported with molecular testing and optimal TNBC treatment.

This hour-long webinar will increase clinician knowledge about RSV including discussing epidemiology and burden of disease, review characteristics that put patients at higher risk of moderate to severe RSV, and improve clinician understanding of diagnostic testing.

This broadcast aims to close knowledge gaps and improve awareness of the significant morbidity and mortality caused by Respiratory Syncytial Virus (RSV) in older adults by reviewing existing management strategies as well as mitigation strategies to improve symptoms, promote resolution, and reduce transmission. The webinar will also cover the development status of antiviral therapies, different types of vaccines and their associated targets as well as safety and efficacy data from recent clinical trials.

This CME-certified Tweetorial aims to close knowledge gaps and improve awareness of the significant morbidity and mortality caused by Respiratory Syncytial Virus (RSV) infection, especially in older adults. This activity will address RSV prevalence, shed light on the burden of RSV, risk factors for complications and severe disease in adults, the impact of COVID-19 on RSV, seasonality, and hospitalization data.

This CME-certified Tweetorial activity focuses on the symptom profile of Respiratory Syncytial Virus (RSV), symptom overlap with other respiratory tract infections, methods for detecting and confirming an RSV diagnosis; specifically reviewing available tests including specificity and sensitivity data.

This Twitter-based, CME-certified Tweetorial activity will focus on Respiratory Syncytial Virus (RSV) mitigation strategies and delve into the pros and cons of vaccine candidates, specifically the development of protein subunits vaccines for older adults.

This Twitter-based, CME-certified Tweetorial activity will focus on Respiratory Syncytial (RSV) Adenovirus Type 26 Viral Vectors vaccine candidates, how they work, their effectiveness, and safety information.

This Twitter-based, CME-certified Tweetorial activity will focus on Respiratory Syncytial Virus (RSV) mitigation strategies and delve into the pros and cons of vaccine candidates, specifically the development of mRNA vaccines for older adults.

This Twitter-based, CME-certified Tweetorial activity will focus on Respiratory Syncytial Virus (RSV) mitigation strategies and delve into the pros and cons of vaccine candidates, specifically the development of recombinant viral vector vaccines for older adults.

This video-based Consult with the Expert will increase awareness of short bowel syndrome (SBS), as well as comprehensive care and management of pediatric patient with SBS.

This CME-certified, Tweetorial will focus on total parenteral nutrition (TPN) in patients with SBS, covering benefits, dependency, and complications.

This CME-certified, MondayNightIBD Case Conversation will address care of a standardized adult patient suspected of having SBS. The program moderator and co-moderator, in partnership with #MondayNightIBD will host an online Twitter Chat to review diagnostic and management options.

This CME-certified, Twitter-based video Consult with the Expert, will focus on medical management for both adult and pediatric patients with SBS.

This CME-certified, Tweetorial will focus on pharmacologic treatment for patients with SBS.

This CME-certified, MondayNightIBD Case Conversation will address care of an young adult patient SBS. The program moderator and co-moderator, in partnership with #MondayNightIBD will host an online Twitter Chat to review diagnostic and management options.

In partnership with Tumor Board Tuesday, this CME-certified, Tweetorial reviews the latest data related to anti-angiogenic therapies and immune checkpoint inhibitors in Hepatocellular Carcinoma (HCC). An assessment of associated toxicities of these agents will lead learners to evaluate how these toxicities may impact treatment selection and management.

This CME-certified, Twitter-based video Fireside Chat will assess safety of anti-angiogenic therapy and immune checkpoint inhibitor treatments, particularly when used in combinations in Hepatocellular Carcinoma (HCC). Strategies to prevent, evaluate and manage common adverse events (AEs) and immune-related adverse events (irAEs) will be reviewed.

In partnership with Tumor Board Tuesday, this CME-certified, Tweetorial reviews the latest data related to anti-angiogenic therapies and immune checkpoint inhibitors in Endometrial Carcinoma (EC). An assessment of associated toxicities of these agents will lead learners to evaluate how these toxicities may impact treatment selection and management.

In partnership with Tumor Board Tuesday, this CME-certified, Twitter-based video Fireside Chat will assess safety of anti-angiogenic therapy and immune checkpoint inhibitor treatments, particularly when used in combinations in Endometrial Carcinoma (EC). Strategies to prevent, evaluate and manage common adverse events (AEs) and immune-related adverse events (irAEs) will be reviewed.

In partnership with Tumor Board Tuesday, this video Fireside Chat will assess safety of TKI/IO therapy, particularly when used in combinations in Renal Cell Carcinoma (RCC). Strategies to prevent, evaluate and manage common TRAEs and irAEs will be reviewed.

In partnership with Tumor Board Tuesday, this CME-certified, Tweetorial reviews the latest data related to anti-angiogenic therapies and immune checkpoint inhibitors in Renal Cell Carcinoma (RCC). An assessment of associated toxicities of these agents will lead learners to evaluate how these toxicities may impact treatment selection and management.

This CME-certified, live Zoom-based webinar focuses on the epidemiology of PAF in CD, as well as prognosis, burden, treatment goals and management. A portion of the webinar is dedicated to focusing on the patient perspective.

The archived recording of this program will be made available at a later date (in 2023).